In glioma, some synthetic compounds have been found to induce the G1 phase arrest of tumor cells by inhibiting EZH2 expression and reducing the inhibitory effect of PRC2 on p21, p27, and p16 gene expression (Mohammad et al., 2017; Stazi et al., 2019). Here, CDKN2A is linked to glioma.